Sato, K., White, N., Fanning, J., Obonyo, N., Yamashita, M., Appadurai, V., . . . Investigators, C. C. C. C. (2022). Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: A prospective cohort study. BioMed Central.
Chicago Style (17th ed.) CitationSato, K., et al. Impact of Renin–angiotensin–aldosterone System Inhibition on Mortality in Critically Ill COVID-19 Patients with Pre-existing Hypertension: A Prospective Cohort Study. BioMed Central, 2022.
MLA引文Sato, K., et al. Impact of Renin–angiotensin–aldosterone System Inhibition on Mortality in Critically Ill COVID-19 Patients with Pre-existing Hypertension: A Prospective Cohort Study. BioMed Central, 2022.
警告：這些引文格式不一定是100％准確.